Healthcare Innovation June 27, 2024
Geert De Lombaerde

‘We intend to remain an investor and partner,’ CEO Tim Wentworth said of the clinic venture that earlier this year required a massive write-off.

The leaders of Walgreens Boots Alliance Inc. are preparing to move on from at least some of their investment in primary care chain VillageMD, which plays a vital role in the company’s healthcare delivery strategy.

CEO Tim Wentworth, who took over Illinois-based Walgreens last fall, and his team are calling their plan to shrink their 53 percent stake in Village part of a simplification of their healthcare portfolio that itself is a piece of a broad strategic review. Speaking to analysts on a June 27 conference call discussing Walgreens’ fiscal third-quarter earnings, Wentworth said Walgreens’ leaders...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech, Primary care, Provider
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
Survey Suggests Pharma Industry Still Struggling with Digital Transformation
Will Walgreens’ store closures disrupt its clinical trial aims?
340B Legal Challenges Highlight The Appetite For Innovation That Supports The Program’s Goals
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights

Share This Article